Nurse Practitioner, Family · Hot Springs, AR
NPI
1932793445
Since 2021
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
1900 Malvern Ave Ste 403
Hot Springs, AR, 71901
Phone (501) 500-5001
Groups this clinician bills Medicare through
Medicare paid, 2024
$278K
29,615 services
Medicare patients, 2024
490
Average age 72
Drug cost, 2024
$3.7M
9,079 prescriptions
Company payments, 2025
$1,797
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert C McDaniels was code J0897 (injection, denosumab, 1 mg), 780 times for 13 patients. In total Robert C McDaniels billed 29,615 services in 41 codes, and Medicare paid $278K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 780 | 13 | $19.62 | $15K |
| 99214 Office E&M - Established | Office | 375 | 281 | $58.93 | $22K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 372 | 32 | $0.71 | $263 |
| 99213 Office E&M - Established | Office | 227 | 208 | $41.68 | $9,461 |
| 86235 Immunoassay | Office | 161 | 20 | $17.57 | $2,829 |
| 96372 Injection Administration | Office | 101 | 25 | $8.51 | $860 |
| 96415 Chemotherapy Administration | Office | 47 | 21 | $15.57 | $732 |
| 96413 Chemotherapy Administration | Office | 41 | 22 | $72.85 | $2,987 |
| 82306 Clinical Chemistry | Office | 40 | 36 | $29.01 | $1,160 |
| 96365 Intravenous Infusion, Hydration | Office | 40 | 19 | $35.81 | $1,433 |
| 20610 Joint Injection | Office | 26 | 23 | $48.41 | $1,259 |
| 71046 X-ray - Chest | Office | 23 | 23 | $13.87 | $319 |
| 86226 Immunoassay | Office | 23 | 20 | $11.87 | $273 |
| 86225 Immunoassay | Office | 23 | 20 | $13.47 | $310 |
| 99212 Office E&M - Established | Office | 12 | 12 | $28.27 | $339 |
By year: 2022 $371K for 25,974 services; 2023 $669K for 64,013 services; 2024 $278K for 29,615 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86235 Immunoassay | 161 | 20 | $17.57 | $2,829 |
| 82306 Clinical Chemistry | 40 | 36 | $29.01 | $1,160 |
| 86225 Immunoassay | 23 | 20 | $13.47 | $310 |
| 86226 Immunoassay | 23 | 20 | $11.87 | $273 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert C McDaniels prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,733 prescriptions and refills. In total Robert C McDaniels wrote 9,079 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,733 | 2,926 | 499 | $54K |
| Prednisone Generic | 1,064 | 1,385 | 313 | $5,927 |
| Methotrexate Methotrexate Sodium | 806 | 1,239 | 202 | $13K |
| Gabapentin Generic | 586 | 886 | 159 | $6,872 |
| Diclofenac Sodium Generic | 427 | 649 | 133 | $9,075 |
| Colchicine Generic | 425 | 623 | 129 | $28K |
| Leflunomide Generic | 421 | 697 | 111 | $18K |
| Sulfasalazine Generic | 391 | 626 | 118 | $5,888 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 346 | 346 | 93 | $9,589 |
| Tramadol Hcl Generic | 301 | 301 | 81 | $2,008 |
| Sulindac Generic | 216 | 337 | 61 | $3,292 |
| Azathioprine Generic | 211 | 295 | 55 | $8,220 |
| Pregabalin Generic | 197 | 220 | 48 | $3,521 |
| Folic Acid Generic | 170 | 323 | 43 | $1,235 |
| Meloxicam Generic | 132 | 218 | 38 | $564 |
Brand drugs: - claims; generic drugs: 8,087 claims; opioid claims: 679.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert C McDaniels $1,797 ($1,797 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $588.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.